Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in Recovery Phase of Septic Shock
NCT02990546Phase 3Withdrawn
- Sponsor
- University of Virginia
- Start
- Mar 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of midodrine in septic shock, sponsored by University of Virginia. Planned start Mar 2017; status: withdrawn.
02
Drugs
midodrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02990546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02990546.